The goal of this type I hybrid effectiveness-implementation trial is to test a family strengthening (FS) model delivered through multiple family groups (MFG) combined with a virtual peer mentoring program called TeenAge Health Consultants (Virtual TAHC) aimed at addressing emotional and behavioral problems among youth born in the U.S. to parents resettled as refugees. The specific aims of the study are: Aim 1: To systematically adapt an evidence-based family strengthening (FS) model delivered through multiple family groups (MFG) combined with a peer mentoring program (Virtual TAHC) (Goal 1). Aim 2: To assess preliminary short- and long-term impact of the combination intervention (MFG + Virtual TAHC) on behavioral emotional disorders (aggressive behavior, antisocial behaviors, anxiety, depression, and Posttraumatic Stress Disorder \[PTSD\]) related to intergenerational trauma among SGRC in the trial (Goal 2). Aim 3: Utilizing mixed methods and applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework, examine implementation strategies, facilitators, and barriers of the RRF4H intervention (Goal 3). Participants will receive: 1. Family strengthening intervention delivered through multiple family groups (MFG) where children and one of their biological parents will participate in 16 weekly group sessions to discuss common problems and how to address them. 2. The youth in the intervention will participate in a peer mentorship program called TeenAge Health Consultants (TAHC) consisting of 16 weekly virtual sessions where they interact with other youth to learn about important topics including how to deal with conflict, stay out of trouble, deal with stress, avoid drugs and other topics. Researchers will compare the intervention group to a control group that will receive the usual care to see if the intervention group shows improvement in symptoms compared to the usual care group.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Improvement in Post-Traumatic Stress Disorder (PTSD) Symptoms among adolescents
Timeframe: Baseline, 16 Weeks post-intervention, and 6 months
Improvement in Post-Traumatic Stress Disorder (PTSD) Symptoms among adults
Timeframe: Baseline, 16 Weeks post-intervention, and 6 months
Improvement in Depression Symptoms among adults
Timeframe: Baseline, 16 Weeks post-intervention, and 6 months
Improvement in Depression Symptoms among adolescents
Timeframe: Baseline, 16 Weeks post-intervention, and 6 months
Improvement in Anxiety Symptoms among adults
Timeframe: Baseline, 16 Weeks post-intervention, and 6 months
Improvement in Anxiety Symptoms among adolescents
Timeframe: Baseline, 16 Weeks post-intervention, and 6 months
Improvements in Antisocial Behavior Symptoms (adolescents only)
Timeframe: Baseline, 16 Weeks post-intervention, and 6 months
Improvement in Aggressive Behavior Symptoms (adolescents only)
Timeframe: Baseline, 16 Weeks post-intervention, and 6 months